Category: Equity Research Report

  • Bajaj Auto Delivers Record-Breaking FY25 – On Track for Another Stellar Year in FY26

    Bajaj Auto Delivers Record-Breaking FY25 – On Track for Another Stellar Year in FY26

    Bajaj Auto reported its best-ever financial performance in FY25, driven by a strong rebound in exports, leadership in electric 2- and 3-wheelers, a diversified product strategy in the domestic market, and disciplined cost management. Despite macroeconomic challenges and KTM Austria’s struggles, the company remains confident of delivering another record year in FY26.

    FY25 Highlights: Financial Performance:

    a) Revenue crossed ₹50,000 Cr for the first time (+12% YoY).
    b) EBITDA: ₹10,101 Cr with steady margins at 20.2%.
    c) Standalone PAT: ₹8,151 Cr (+9% YoY); Consolidated PAT: ₹7,325 Cr (KTM drag).
    d) Free Cash Flow: ₹6,500 Cr | Cash Reserves: ₹17,000 Cr.
    e) Dividend: ₹210/share (₹5,900 Cr payout, 72% payout ratio).

    Exports – Strong Comeback:
    a) Q4 Export Volumes: +20% YoY | Bajaj grew 31% vs. industry 26%.
    b) LATAM Focus: Now the largest export region; Brazil plant expanding to 50k capacity by Dec 2025.
    c) Premium Mix: 65% of exports are Pulsar, Dominar.
    d) KTM Exports: Temporarily suspended; expected to resume next quarter.
    e) Guidance: 15–20% YoY export growth expected each quarter in FY26.

    Domestic Motorcycles – Realigning for Growth:
    a) Industry growth: 6% in FY25 (125cc+ segment up 12%).
    b) Bajaj’s 125cc+ market share: 24% (FY23: 21%, FY24: 26%).

    Actions Taken:
    a) 6 new Pulsar variants launched.
    b) Launch of Freedom CNG bike: 60,000 units retailed.

    FY26 Outlook: Industry to grow 5–6%; Bajaj targeting share gains with new launches.

    Electric 3-Wheelers – Bajaj Becomes India’s #1:
    a) Market share jumped from 17% to 33% in FY25.
    b) Launched GoGo electric brand; e-rickshaw to debut in July 2025.
    c) Focus: Upgrading fragmented e-rickshaw market with quality & reliability.

    Electric 2-Wheelers – Chetak Takes the Lead:
    a) Market leader with 25% share in Q4 FY25 (up from 13% YoY).
    b) Launched 35 series platform: premium design, better range, fast charging.
    c) Network: 310 experience centers, 3,000+ sales points.
    d) Nearing EBITDA breakeven (helped by PLI).

    Key Risk: Rare earth magnet supply from China may disrupt EV production from July.

    KTM & Triumph – India Growth + Global Restructuring:
    a) KTM + Triumph volumes: ~1 lakh units (+12% YoY).
    b) Triumph India volumes doubled; store network doubled.
    c) KTM Austria in distress due to e-bike failure & debt.
    d) Strategic Move: Bajaj to acquire controlling stake in PBAG (KTM’s parent); turnaround plan in motion with synergies & governance revamp.
    e) FY26-end expected to show first results.

    Bajaj Auto Credit (BACL) – Financial Arm Scaling Fast:
    a) Turned profitable in FY25 (first full-year PAT).
    b) Disbursals: ₹10,000 Cr | AUM: ₹9,500 Cr.
    c) 40–50% penetration in vehicle financing.
    Operates at arm’s length with strong risk controls.

    Key Financials – Q4 FY25:
    Metric Q4 FY25.
    Revenue ₹12,148 Cr (+6% YoY).
    EBITDA ₹2,451 Cr (20.2% margin).
    PAT ₹2,049 Cr (+6% YoY).

    Risks & Headwinds:
    KTM losses dragging consolidated PAT.
    Rare earth supply delays from China for EVs.
    Commodity cost inflation (aluminum, rubber, OBD IIb norms).
    Domestic 2W demand volatility in southern markets.

    FY26 Strategic Thrusts (7-Focus Areas):
    Strengthen 125cc+ position in India.
    Outpace market growth in exports.
    Scale Chetak, GoGo, Freedom, Brazil business.
    Execute KTM turnaround & capture synergies.
    Grow spares business.
    Elevate KTM/Triumph customer experience.
    Balance growth and profitability amidst volatility.

    Management Outlook: “FY26 to be another record year with best-in-class financial performance.”

    Bajaj Auto ltd

  • Dr. Reddy’s Laboratories: Strong Growth, Rising Capex, But Is the Market Missing the Story?

    Dr. Reddy’s Laboratories: Strong Growth, Rising Capex, But Is the Market Missing the Story?

    🔬 Dr. Reddy’s Laboratories Ltd is showing all the right signs of aggressive expansion.
    Despite a decline in EBITDA margins this year, the company has:

    ✔️ Maintained steady sales growth
    ✔️ Increased borrowings (₹2,002 Cr → ₹4,677 Cr) to fund capex
    ✔️ Grown its fixed assets from ₹10,426 Cr to ₹18,293 Cr — a clear sign of future capacity expansion
    ✔️ Managed operating expenses well

    ⚠️ However, rising trade receivables remain a concern — a key area where management needs to focus.

    📉 Interestingly, the stock’s price CAGR is lagging behind the company’s strong compound sales and profit growth.
    ➡️ This could be an opportunity — the stock appears undervalued at current levels.

    💡 Is the market underestimating Dr. Reddy’s long-term growth story?

    Let me know your thoughts in the comments! 👇

    DRREDDY REPORT

  • MTAR Technologies: Rising Costs, Falling Profits, and Promoter Exit – Time to Reassess?

    MTAR Technologies: Rising Costs, Falling Profits, and Promoter Exit – Time to Reassess?

    MTAR Technologies har quarter naye bade targets announce karti hai – ₹700 Cr+ revenue, 28% EBITDA margin, aur clean energy + aerospace sector mein aggressive growth ke promises.
    Lekin jab actual numbers dekhte hain to kahani alag milti hai:

    Material cost FY23-24 mein 52% tak pahunch gaya, jo margin par direct pressure daal raha hai.

    Profit after tax sirf ek saal mein 104 Cr se gir kar 56 Cr ho gaya.

    Promoters June 2022 ke 47.47% stake se gir ke sirf 31.77% par aa gaye hain, aur usme bhi 10.4% holding girvi rakhi gayi hai.

    Management bar-bar confidence dikhata hai, lekin jab promoters hi apna stake nikal rahe ho, to investor ka trust kahaan se aaye?

    Is report mein humne company ke financials, ground reality, aur management ke behavior ko detail mein decode kiya hai – taaki aap hype ke peechhe chhupe risk ko samajh sakein.

    MTAR TECHNOLOGIES EQUITY RESEARCH REPORT

  • HUL: Sleeping Giant Ready to Break Out?

    HUL: Sleeping Giant Ready to Break Out?

    📈 Equity Research Update: Hindustan Unilever Ltd (HUL)
    Over the past 2–3 years, HUL’s stock has been consolidating in a sideways trend, but recent management commentary and structural investments signal potential upside ahead.

    🔍 Key Highlights:
    ✅ Strong focus on premiumization, innovation, and market-making
    ✅ Expected EBITDA improvement post 2–3 quarters
    ✅ Home Care segment sees robust volume growth; liquids expanding 5x faster
    ✅ Beauty & Wellbeing: Hair Care shines, Skin Care faces near-term softness
    ✅ Stock may witness a breakout if supported by volume and bullish price action

    With sustained capex since 2021 and favorable tailwinds like stable raw material prices, HUL could be gearing up for a new growth phase—both fundamentally and technically.

    📊 If you’re tracking FMCG giants or looking for stable compounders, this is one to watch!

    HUL Equity Report

  • Pharma Sector Financial Overview

    Pharma Sector Financial Overview

    📊 Pharma Sector Financial Overview: Key Insights from the Latest Report 💊

    🔹 Fixed Assets & Borrowings – How are capital investments and leverage impacting the sector?
    🔹 Shareholding Pattern – Are promoters, FIIs, and DIIs increasing or decreasing their stake?
    🔹 Reserves & Revenue Growth – Are companies showing strong financial health?
    🔹 EBITDA Margins – What do profitability trends indicate?

    The value migration in the pharma sector is at an interesting stage. R&D investments, API self-sufficiency, and global supply chain diversification are shaping long-term growth. 📈

    What’s your take on this? Share your views in the comments! 👇

    PHARMA SECTOR STOCKS

  • Shipbuilding Industry – A Perfect Cyclical Opportunity?

    Shipbuilding Industry – A Perfect Cyclical Opportunity?

    🚢 Shipbuilding Industry – A Perfect Cyclical Opportunity?
    Just completed an in-depth research report on the Global Shipbuilding Cycle, based on insights from:

    📘 Crisil Industry Intelligence Report
    📙 GoldenPi Prime Research (Shipping & Shipbuilding Sector)

    Covered in the Report:

    Why everything in investing is cyclical – especially sectors like shipbuilding
    How post-COVID demand boom + ESG shift created a supply crunch

    Why capex trends, aging fleet, and IMO 2030 regulations are triggering a new upcycle

    Freight index & steel price analysis → What it means for margins

    Case for strong revenue visibility till 2027

    Timing the cycle = spotting the opportunity.

    With strong order books, rising prices, and falling input costs, the sector might be entering a sweet spot.

    📝 This study is purely educational and created using publicly available research content from CRISIL and GoldenPi Prime.

    💬 Would love to hear your views on this!

    ShipBuilding Sector

  • Indus Towers Ltd: Strong Cash Flows, Strategic Capex & Bullish Technical Setup | Equity Research 2025

    Indus Towers Ltd: Strong Cash Flows, Strategic Capex & Bullish Technical Setup | Equity Research 2025

    This short research report on Indus Towers Ltd. provides a focused analysis of the company’s recent financial performance, technical chart setup, and key fundamental trends. It highlights the bullish head-and-shoulder pattern on the monthly chart, improving EBITDA margins, rising capex, and concerns around promoter stake dilution. The report is meant to help readers quickly understand the current positioning of Indus Towers within the telecom infrastructure space, and the potential upside and risks ahead.

    INDUS TOWER RESEARCH REPORT

  • Dabur India Ltd – A Top-Down Equity Research Report

    Dabur India Ltd – A Top-Down Equity Research Report

    I am thrilled to share my first Equity Research Report on Dabur India Limited. In this report, I have adopted a top-down approach to present a detailed and comprehensive analysis of the company. From assessing the broader global & Indian economy and FMCG industry trends to conducting an in-depth examination of Dabur’s financials, product portfolio, and management outlook, this report covers it all.

    Key Highlights of the Report:
    ✅ Company Overview
    ✅ Economy Overview
    ✅ Sector Overview
    ✅ Industry Analysis
    ✅ Results Analysis
    ✅ Management Analysis
    ✅ Financial Statement Analysis
    ✅ Key Metrics
    ✅ Ratio Analysis
    ✅ Peers Analysis
    ✅ Analyst Coverage

    DABUR EQUITY RESEARCH REPORT

WhatsApp chat